openPR Logo
Press release

How much will the Global Antibody Drug Conjugates (ADC) Market grow in 2017-2022? Seattle Genetic, Takeda, ImmunoGen, Sanofi profiled

03-20-2018 12:35 PM CET | Health & Medicine

Press release from: Research By Markets

Global Antibody Drug Conjugates (ADC) 2017-2022

Global Antibody Drug Conjugates (ADC) 2017-2022

ResearchByMarkets / Press Release / Pharmaceuticals, "Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)" 154 Pages, 10 Companies Profiled.

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

More Information: https://www.researchbymarkets.com/report/global-antibody-drug-conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and-forecasts-2017-2022-by-region-n-america-europe-apac-row-by-country-us-ica-5271.html

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

According to this research report, Global Antibody Drug Conjugates (ADC) Market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 - 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, "Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Inquire more about this report: https://www.researchbymarkets.com/inquiry/5271

Company Profiling
F. Hoffmann-La Roche Ltd
Seattle Genetics
Takeda
ImmunoGen Inc
Pfizer Inc.
Sanofi
AbbVie Inc
Cellldex Therapeutics
Synthon
Progenics Pharmaceuticals

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Antibody Drug Conjugates Market (ADC) Market
• Adcetris Market
• Kadcyla Market
• ADC Pipeline - By Developer, Phase, Indication and Status
• ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets - N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Antibody Drug Conjugates Market (ADC) Market
• Adcetris Market
• Kadcyla Market
• ADC Pipeline - By Developer, Phase, Indication and Status
• ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:
• Market Dynamics - Trends, Drivers, Challenges
• Porter's Five Forces Analysis
• SWOT Analysis
• Policy and Regulation
• Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Contact:
ResearchByMarkets
Ms. Lia Seth | Client Relations Manager
enquiry@researchbymarkets.com

Research By Markets is an online Market Research Report Repository.

Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more.

Research By Markets
3, Nagar Road,
Pune 411 014, Maharashtra, India
enquiry@researchbymarkets.com
+1-800-416-3124

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release How much will the Global Antibody Drug Conjugates (ADC) Market grow in 2017-2022? Seattle Genetic, Takeda, ImmunoGen, Sanofi profiled here

News-ID: 985558 • Views:

More Releases from Research By Markets

V2X (Vehicle-to-Everything) Communications Ecosystem expected to grow at a CAGR of more than 170% between 2019 and 2022
V2X (Vehicle-to-Everything) Communications Ecosystem expected to grow at a CAGR …
Commonly referred to as V2X, vehicle-to-everything communications technology allows vehicles to directly communicate with each other, roadside infrastructure, and other road users to deliver an array of benefits in the form of road safety, traffic efficiency, smart mobility, environmental sustainability, and driver convenience. In addition, V2X is also helping pave the way for fully autonomous driving through its unique non line-of-sight sensing capability which allows vehicles to detect potential hazards,
Research By Markets - Trusted By Market Leaders
Research By Markets - Trusted By Market Leaders
Research By Markets is a Market Research Reports Online Repository. We have a huge database of syndicated market research reports that are segmented by Industry Verticals mainly - Telecommunication, Semiconductor, Electronics, Information Technology, Automotive, Healthcare, Pharmaceutical, Medical Devices, Biotechnology, Energy, Power, Aerospace, Defense, Consumer Goods, Construction, Equipment and many more. Our clientele includes Fortune listed companies who trust us to help them with their market intelligence requirements. Research By Markets being a
Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022) - ResearchByMarkets.com
Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022) - Rese …
The report titled "Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022)", provides an in depth analysis of the global veterinary services market by value, by segments, by services, by region, etc. The report also provides a regional analysis of the veterinary services market, including the following regions: North America, Europe, Asia Pacific, Latin America and MEA. The report also assesses the key opportunities in the market and outlines the factors
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - ResearchByMarkets.com
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Researc …
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas, a

All 5 Releases


More Releases for ADC

ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments. Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion Key
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology. New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates. New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313. Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg "2023
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment. On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends. This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering National Semiconductor Nippon Precision Circuits Inc Micro Analog systems Microchip Technology. TelCom Semiconductor, Inc Vishay Siliconix Texas